WEBVTT

00:00:02.400 --> 00:00:06.910
What if a tiny peptide could ask the
pituitary gland to release growth hormone?

00:00:07.920 --> 00:00:13.330
Meet ipamorelin: five amino acids designed
to trigger that signal.

00:00:14.370 --> 00:00:20.050
In 1998, Kirsten Raun and colleagues at
Novo Nordisk in Denmark reported its

00:00:20.050 --> 00:00:20.760
discovery.

00:00:21.800 --> 00:00:24.910
Researchers have studied it for almost
three decades.

00:00:25.750 --> 00:00:29.870
Ipamorelin activates the ghrelin receptor,
part of the body's growth-hormone

00:00:29.870 --> 00:00:30.900
signaling system.

00:00:31.680 --> 00:00:37.620
CJC-1295 and tesamorelin act through a
different receptor, the

00:00:37.620 --> 00:00:39.920
growth-hormone-releasing hormone receptor.

00:00:40.920 --> 00:00:45.640
In the original pig experiments, ipamorelin
stimulated growth hormone without

00:00:45.640 --> 00:00:49.590
the same rise in cortisol seen with some
older secretagogues.

00:00:50.300 --> 00:00:52.360
That selectivity attracted interest.

00:00:53.070 --> 00:00:58.870
A 1999 study in healthy men then showed a
brief growth-hormone response after

00:00:58.870 --> 00:01:01.050
intravenous ipamorelin.

00:01:01.750 --> 00:01:05.780
It measured hormone release, leaving
long-term health benefits unanswered.

00:01:06.440 --> 00:01:09.460
Researchers also explored ghrelin signaling
in the gut.

00:01:09.920 --> 00:01:14.470
A randomized trial enrolled 117
bowel-surgery patients.

00:01:15.360 --> 00:01:20.220
The ipamorelin group tolerated a meal
sooner numerically, but the difference was

00:01:20.220 --> 00:01:21.670
not statistically significant.

00:01:22.530 --> 00:01:26.440
So where do the muscle, sleep and
anti-aging claims fit?

00:01:27.110 --> 00:01:30.790
A hormone response alone cannot establish
those benefits.

00:01:31.510 --> 00:01:36.500
Different receptor pathways also cannot
tell us how much benefit a particular

00:01:36.500 --> 00:01:38.360
peptide combination provides.

00:01:39.020 --> 00:01:44.080
As of November 2026, ipamorelin has no
FDA-approved medicine.

00:01:44.750 --> 00:01:50.190
FDA has raised concerns about immune
reactions, peptide impurities and limited

00:01:50.190 --> 00:01:51.330
safety evidence.

00:01:52.050 --> 00:01:56.200
Its story connects molecular design, human
hormone measurements and an

00:01:56.200 --> 00:02:01.100
unfinished clinical question: which effects
translate into meaningful benefits?

00:02:01.640 --> 00:02:03.250
World Peptide Foundation.

00:02:03.820 --> 00:02:05.080
Peptides in 2.

00:02:05.510 --> 00:02:07.110
Every experience matters.
